- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate Language Delay in New Zealand
Total 203 results
-
Merz North America, Inc.Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)United States
-
Hennepin Healthcare Research InstituteNational Institute on Drug Abuse (NIDA); The Emmes Company, LLCRecruitingSubstance Use Disorder | Opioid Use Disorder, Moderate | Opioid Use Disorder, SevereUnited States
-
Kessler FoundationUCB PharmaActive, not recruitingStroke | AphasiaUnited States
-
Hennepin Healthcare Research InstituteNational Institute on Drug Abuse (NIDA); The Emmes Company, LLCRecruitingSubstance Use Disorders | Opioid Use Disorder, Moderate | Opioid Use Disorder, SevereUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
Dana-Farber Cancer InstituteNational Institute on Aging (NIA)CompletedCovid19 | Advanced Care Planning | Shared Decision Making | Advance Directives | Communication Skills | Video Decision Aids | Natural Language ProcessingUnited States
-
Kessler FoundationCompletedStroke | Aphasia | Spatial NeglectUnited States
-
Qurient Co., Ltd.CompletedModerate to Severe Atopic DermatitisUnited States
-
Debiopharm International SACompletedModerate Alzheimer's DiseaseAustralia, Canada, United Kingdom
-
UCB Biopharma S.P.R.L.CompletedModerate and Severe Active Rheumatoid Arthritis | Active Psoriatic Arthritis | Active Ankylosing Spondylitis | Moderately to Severely Active Crohn's DiseaseUnited States
-
Scilex Pharmaceuticals, Inc.Worldwide Clinical TrialsCompletedModerate to Severe Acute Lower Back PainUnited States
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Colombia, Estonia, Japan, Taiwan, Israel, Canada, Lithuania, Argentina, Latvia, Iceland, Mexico
-
Incyte CorporationRecruitingModerate to Severe AsthmaKorea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
-
Helius Medical IncRecruitingGait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)United States
-
UCB Biopharma SRLRecruitingModerate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis | Mixed Guttate/Plaque PsoriasisUnited States, Canada, Puerto Rico
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | DyslexiaUnited States
-
BayerCompletedModerate Risk of CVDPoland, United States, Italy, United Kingdom, Germany, Spain, Puerto Rico, Ireland
-
Indivior Inc.Active, not recruitingModerate to Severe Opioid-use DisorderUnited States, Canada
-
Inmagene LLCTerminatedAtopic Dermatitis | Moderate-to-severe Atopic Dermatitis | ADCanada, United States
-
Oneness Biotech Co., Ltd.RecruitingMild to Moderate COVID-19Taiwan, United States
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisBelgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
Universitätsklinikum KölnHannover Medical School; Miltenyi Biomedicine GmbH; ZKS KölnTerminatedModerate COVID-19-infectionGermany
-
Kessler FoundationRecruitingStroke | Dyslexia, AcquiredUnited States
-
Actinogen MedicalRecruitingAlzheimer Disease | Dementia, Mild | Dementia ModerateAustralia
-
Genentech, Inc.TerminatedModerate-to-severe Allergic AsthmaUnited States
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
Alkahest, Inc.CompletedAlzheimer Disease | Mild to Moderate Alzheimer DiseaseUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
UnicoCell Biomed CO. LTDProtech Pharmaservices Corporation (PPC)CompletedModerate to Severe Chronic Kidney DiseaseTaiwan
-
AmgenTerminatedModerate to Severe Rheumatoid ArthritisUnited States, Canada, Puerto Rico
-
Kessler FoundationNot yet recruitingStroke | Aphasia | Reading DisorderUnited States
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Herbert H. Lehman College, City University of New...University of UtahTerminated
-
Columbia UniversityNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
University Hospital MuensterUnknown
-
HanAll BioPharma Co., Ltd.CompletedMild to Moderate Atopic DermatitisUnited States
-
Emalex Biosciences Inc.Premier Research Group plc; University of California, RiversideCompletedChildhood-Onset Fluency Disorder (Stuttering)United States
-
Medtronic CardiovascularRecruitingModerate Aortic Valve StenosisUnited States, France, Netherlands, Canada, Spain, Israel, Australia, Denmark, Germany, Italy, Japan, Switzerland, Belgium, Sweden, Austria, United Kingdom, Ireland
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
-
Columbia UniversityNational Institute of Neurological Disorders and Stroke (NINDS)CompletedTauopathies | Frontotemporal Dementia (FTD) | Frontotemporal Lobar Degeneration (FTLD)United States
-
Convexity Scientific IncCOPD FoundationCompletedChronic Obstructive Pulmonary Disease | COPD | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereUnited States
-
NYU Langone HealthCompletedPrimary Progressive AphasiaUnited States
-
Columbia UniversityAlzheimer's Drug Discovery FoundationCompletedFrontotemporal Dementia (FTD)United States
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
Kessler FoundationUniversity of California, San Diego; University of Michigan; Rehabilitation Hospital... and other collaboratorsRecruitingDementia | Traumatic Brain Injury | Alzheimer's Disease | Mild Traumatic Brain Injury | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateUnited States
-
AmgenActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic DermatitisUnited States, Canada